Capital City Trust’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.4M | Buy |
23,073
+323
| +1% | +$18.8K | 0.32% | 59 |
|
|
2025
Q4 | $1.23M | Sell |
22,750
-646
| -3% | -$31.1K | 0.27% | 64 |
|
|
2025
Q3 | $1.06M | Buy |
23,396
+1,314
| +6% | +$61.4K | 0.26% | 66 |
|
|
2025
Q2 | $1.02M | Buy |
22,082
+2,088
| +10% | +$102K | 0.27% | 67 |
|
|
2025
Q1 | $1.22M | Buy |
19,994
+725
| +4% | +$42.3K | 0.33% | 62 |
|
|
2024
Q4 | $1.09M | Sell |
19,269
-1,878
| -9% | -$105K | 0.27% | 65 |
|
|
2024
Q3 | $1.09M | Sell |
21,147
-3,683
| -15% | -$173K | 0.27% | 67 |
|
|
2024
Q2 | $1.03M | Buy |
24,830
+81
| +0.3% | +$3.62K | 0.28% | 65 |
|
|
2024
Q1 | $1.34M | Buy |
24,749
+34
| +0.1% | +$1.73K | 0.37% | 61 |
|
|
2023
Q4 | $1.27M | Sell |
24,715
-1,233
| -5% | -$64.7K | 0.38% | 62 |
|
|
2023
Q3 | $1.51M | Sell |
25,948
-1,887
| -7% | -$116K | 0.5% | 52 |
|
|
2023
Q2 | $1.78M | Sell |
27,835
-1,204
| -4% | -$80.7K | 0.55% | 51 |
|
|
2023
Q1 | $2.01M | Buy |
29,039
+1,677
| +6% | +$118K | 0.64% | 48 |
|
|
2022
Q4 | $1.97M | Sell |
27,362
-695
| -2% | -$52.4K | 0.65% | 49 |
|
|
2022
Q3 | $1.99M | Sell |
28,057
-232
| -0.8% | -$16.8K | 0.7% | 48 |
|
|
2022
Q2 | $2.18M | Buy |
28,289
+52
| +0.2% | +$3.96K | 0.71% | 45 |
|
|
2022
Q1 | $2.06M | Sell |
28,237
-47
| -0.2% | -$3.16K | 0.6% | 53 |
|
|
2021
Q4 | $1.76M | Sell |
28,284
-305
| -1% | -$17.9K | 0.5% | 58 |
|
|
2021
Q3 | $1.69M | Buy |
28,589
+877
| +3% | +$57.8K | 0.52% | 56 |
|
|
2021
Q2 | $1.85M | Sell |
27,712
-405
| -1% | -$26.4K | 0.56% | 54 |
|
|
2021
Q1 | $1.77M | Buy |
28,117
+83
| +0.3% | +$5.16K | 0.56% | 54 |
|
|
2020
Q4 | $1.74M | Sell |
28,034
-2,493
| -8% | -$153K | 0.61% | 48 |
|
|
2020
Q3 | $1.84M | Buy |
30,527
+1,173
| +4% | +$70.6K | 0.67% | 42 |
|
|
2020
Q2 | $1.73M | Buy |
29,354
+978
| +3% | +$58.5K | 0.66% | 45 |
|
|
2020
Q1 | $1.58K | Buy |
28,376
+368
| +1% | +$22.5K | 0.71% | 40 |
|
|
2019
Q4 | $1.8M | Buy |
28,008
+1,951
| +7% | +$112K | 0.68% | 45 |
|
|
2019
Q3 | $1.32M | Buy |
26,057
+311
| +1% | +$14.6K | 0.58% | 52 |
|
|
2019
Q2 | $1.17M | Buy |
25,746
+559
| +2% | +$26K | 0.48% | 56 |
|
|
2019
Q1 | $1.2M | Sell |
25,187
-374
| -1% | -$18.6K | 0.51% | 57 |
|
|
2018
Q4 | $1.33M | Buy |
25,561
+184
| +0.7% | +$9.89K | 0.61% | 49 |
|
|
2018
Q3 | $1.58M | Sell |
25,377
-912
| -3% | -$54.1K | 0.63% | 50 |
|
|
2018
Q2 | $1.46M | Buy |
26,289
+284
| +1% | +$15.3K | 0.62% | 48 |
|
|
2018
Q1 | $1.65M | Sell |
26,005
-539
| -2% | -$34.7K | 0.71% | 43 |
|
|
2017
Q4 | $1.63K | Buy |
26,544
+694
| +3% | +$43.4K | 0.66% | 46 |
|
|
2017
Q3 | $1.44M | Hold |
25,850
| – | – | 0.56% | 53 |
|
|
2017
Q2 | $1.44M | Sell |
25,850
-99
| -0.4% | -$5.39K | 0.56% | 53 |
|
|
2017
Q1 | $1.41M | Sell |
25,949
-645
| -2% | -$35.4K | 0.56% | 56 |
|
|
2016
Q4 | $1.55M | Buy |
26,594
+295
| +1% | +$16.1K | 0.62% | 51 |
|
|
2016
Q3 | $1.42M | Sell |
26,299
-315
| -1% | -$20.2K | 0.57% | 52 |
|
|
2016
Q2 | $1.96M | Buy |
26,614
+1,151
| +5% | +$81.3K | 0.79% | 45 |
|
|
2016
Q1 | $1.63M | Buy |
25,463
+25
| +0.1% | +$1.58K | 0.66% | 46 |
|
|
2015
Q4 | $1.75M | Sell |
25,438
-1,105
| -4% | -$73K | 0.72% | 46 |
|
|
2015
Q3 | $1.57M | Sell |
26,543
-580
| -2% | -$36.8K | 0.66% | 46 |
|
|
2015
Q2 | $1.8M | Sell |
27,123
-35
| -0.1% | -$2.31K | 0.73% | 47 |
|
|
2015
Q1 | $1.75M | Buy |
27,158
+710
| +3% | +$44.4K | 0.71% | 47 |
|
|
2014
Q4 | $1.56M | Sell |
26,448
-2
| -0% | -$113 | 0.64% | 48 |
|
|
2014
Q3 | $1.35M | Buy |
26,450
+405
| +2% | +$20.2K | 0.57% | 54 |
|
|
2014
Q2 | $1.26M | Sell |
26,045
-150
| -0.6% | -$7.39K | 0.53% | 55 |
|
|
2014
Q1 | $1.36M | Buy |
26,195
+145
| +0.6% | +$7.72K | 0.59% | 50 |
|
|
2013
Q4 | $1.39M | Buy |
26,050
+93
| +0.4% | +$4.74K | 0.6% | 51 |
|
|
2013
Q3 | $1.2K | Buy |
25,957
+120
| +0.5% | +$5.27K | 0.53% | 55 |
|
|
2013
Q2 | $1.15M | Buy |
+25,837
| New | +$1.12M | 0.51% | 56 |
|
Other funds holding BMY
VCM
VPM
Capital City Trust's BMY Position: Q1 2026 in Review
Capital City Trust increased its Bristol-Myers Squibb (BMY) stake by 1.4% in Q1 2026, buying an estimated $18.8K and bringing the position to 23,073 shares worth $1.4M. The position accounts for 0.32% of the portfolio, ranked #59.
Capital City Trust first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.18M in Q2 2022. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Capital City Trust held 23,073 shares of Bristol-Myers Squibb worth $1.4M as of Q1 2026.
- Capital City Trust bought 323 Bristol-Myers Squibb shares in Q1 2026, an estimated $18.8K.
- Bristol-Myers Squibb made up 0.32% of Capital City Trust's portfolio in Q1 2026, its #59 holding.
- Capital City Trust first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Capital City Trust's Bristol-Myers Squibb position peaked at $2.18M in Q2 2022.
- 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Capital City Trust's 13F filing for Q1 2026, filed 1 May 2026.